We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
AAOI | Applied Optoelectronics Inc | 11.13 | 0.00 | 0.00% | 0 |
AAON | AAON Inc | 86.73 | 0.00 | 0.00% | 0 |
AAPB | GraniteShares ETF Trust GraniteShares | 16.25 | 0.00 | 0.00% | 0 |
AAPD | Direxion Daily AAPL ETF | 23.46 | 0.00 | 0.00% | 0 |
AAME | Atlantic American Corporation | 1.96 | 0.00 | 0.00% | 0 |
AAL | American Airlines Group Inc | 14.53 | 0.00 | 0.00% | 0 |
AACI | Armada Acquisition Corporation I | 11.14 | 0.00 | 0.00% | 0 |
AADI | Aadi Bioscience Inc | 1.90 | 0.00 | 0.00% | 0 |
AADR | AdvisorShares Dorsey Wright ADR ETF | 60.77 | 0.00 | 0.00% | 0 |
AAGR | African Agriculture Holdings Inc | 0.32 | 0.00 | 0.00% | 0 |
AACG | ATA Creativity Global | 0.89 | 0.00 | 0.00% | 0 |
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that an abstract featuring new preclinical data highlighting ADI-270, an armored allogeneic “off-the-shelf” gamma delta CAR (chimeric antigen receptor) T cell therapy candidate targeting CD70 positive cancers, has been selected for an oral presentation at the ASGCT 27th Annual Meeting taking place from May 7-11, 2024, in Baltimore, MD. The oral presentation will take place on May 10, 2024 in the Targeted Gene and Cell Therapy session, co-chaired by Adicet Bio’s Chief Scientific Officer, ...
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Health Canada has accepted its New Drug Submission (NDS) for trofinetide for the treatment of Rett syndrome, a rare neurodevelopmental disorder. Health Canada has granted Priority Review for Acadia’s submission.
Pilot plant produces qualification samples for strategic customers and demonstrates commercial maturity of internally-developed production process RENO, Nev., April 22, 2024 /PRNewswire/ -- American Battery Technology Company (ABTC) (NASDAQ: ABAT), an integrated critical battery materials company that is commercializing its technologies for both primary battery minerals manufacturing and secondary minerals lithium-ion battery recycling, announced the completion of construction and start of commissioning of its lithium hydroxide (LiOH) pilot plant marking a significant milestone in the commercialization of its internally-developed processes to access an unrealized domestic primary lithium resource.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 66,008.88 | -840.69 | -1.26% | 1.3T | 3,737,406,559 |
ETH | Ethereum | 3,154.76 | -47.30 | -1.48% | 380.02B | 1,652,190,112 |
USDT | Tether USD | 1.00 | 0.00 | 0.00% | 97.84B | 395,371,963 |
BNB | Binance Coin | 601.42 | -3.68 | -0.61% | 94.78B | 344,504,993 |
SOL | Solana | 153.44 | -3.57 | -2.27% | 67.81B | 1,191,886,296 |
STETH | stETH | 3,153.77 | -46.69 | -1.46% | 30.87B | 3,272,649 |
XRP | Ripple | 0.5501 | -0.0065 | -1.17% | 30B | 452,192,623 |
USDC | USD Coin | 0.9999 | -0.0001 | -0.01% | 28.07B | 994,662,024 |
DOGE | Dogecoin | 0.15729 | -0.00394 | -2.44% | 22.56B | 382,383,625 |
TONCOIN | Wrapped TON Coin | 5.57 | -0.3393 | -5.74% | 19.36B | 105,322,481 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions